Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2021 年第 2 季持倉
持倉截至 2021/6/30，2021/8/16 申報。只含多頭部位，變化是跟 2021 年第 1 季比股數。
- 持股檔數
- 112
- 較 2021 年第 1 季 +19
- 總值
- $37.0 億
- 較 2021 年第 1 季 +$1.16 億 (+3.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| VRTXVertex Pharmaceuticals Inc | Stock | 950,000 | $1.92 億 | 5.2% | +639,100+205.6% | 加碼 | 歷史 |
| ABBVAbbVie Inc. | Stock | 1,484,400 | $1.67 億 | 4.5% | −592,800−28.5% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 1,854,000 | $1.43 億 | 3.9% | +93,700+5.3% | 加碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 565,500 | $1.30 億 | 3.5% | +565,500 | 新進 | 歷史 |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 2,963,545 | $1.24 億 | 3.3% | +202,000+7.3% | 加碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 753,000 | $1.22 億 | 3.3% | +277,300+58.3% | 加碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 2,160,000 | $1.15 億 | 3.1% | +896,700+71.0% | 加碼 | 歷史 |
| AVTRAvantor, Inc. | COM | 3,180,000 | $1.13 億 | 3.1% | −1,805,100−36.2% | 減碼 | 歷史 |
| SGENSeagen Inc. | COM | 640,000 | $1.01 億 | 2.7% | +62,100+10.7% | 加碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 882,500 | $8,567 萬 | 2.3% | −167,300−15.9% | 減碼 | 歷史 |
| HOLXHologic Inc | COM | 1,208,800 | $8,065 萬 | 2.2% | +1,208,800 | 新進 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 4,615,000 | $7,924 萬 | 2.1% | +769,000+20.0% | 加碼 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 2,750,000 | $7,857 萬 | 2.1% | −90,000−3.2% | 減碼 | 歷史 |
| EXASExact Sciences Corp | COM | 590,000 | $7,334 萬 | 2.0% | −8,000−1.3% | 減碼 | 歷史 |
| MDTMedtronic plc | Stock | 535,000 | $6,641 萬 | 1.8% | −489,200−47.8% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 681,000 | $6,628 萬 | 1.8% | +159,600+30.6% | 加碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 6,966,376 | $6,486 萬 | 1.8% | −555,565−7.4% | 減碼 | 歷史 |
| ARNAArena Pharmaceuticals Inc | COM NEW | 943,000 | $6,431 萬 | 1.7% | +44,450+4.9% | 加碼 | 歷史 |
| BIIBBiogen Inc. | COM | 183,900 | $6,368 萬 | 1.7% | +183,900 | 新進 | 歷史 |
| NEONeogenomics Inc | COM NEW | 1,367,000 | $6,175 萬 | 1.7% | +1,367,000 | 新進 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 380,000 | $6,153 萬 | 1.7% | +380,000 | 新進 | 歷史 |
| NBPNovaBridge Biosciences | SPONSORED ADS | 729,000 | $6,120 萬 | 1.7% | −600,000−45.1% | 減碼 | 歷史 |
| CTLTCatalent, Inc. | COM | 540,000 | $5,839 萬 | 1.6% | −20,000−3.6% | 減碼 | 歷史 |
| STTKShattuck Labs, Inc. | COM | 1,940,200 | $5,625 萬 | 1.5% | +609,815+45.8% | 加碼 | 歷史 |
| CNCCentene Corp | Stock | 751,200 | $5,479 萬 | 1.5% | +751,200 | 新進 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 568,000 | $5,319 萬 | 1.4% | −13,000−2.2% | 減碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 563,200 | $4,954 萬 | 1.3% | +17,200+3.2% | 加碼 | 歷史 |
| NTRANatera, Inc. | COM | 436,000 | $4,950 萬 | 1.3% | +40,400+10.2% | 加碼 | 歷史 |
| SHCSotera Health Co | COM | 1,910,000 | $4,628 萬 | 1.3% | +749,000+64.5% | 加碼 | 歷史 |
| XLRNAcceleron Pharma Inc | COM | 358,500 | $4,499 萬 | 1.2% | +35,700+11.1% | 加碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,070,000 | $4,345 萬 | 1.2% | +598,000+40.6% | 加碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 236,400 | $4,241 萬 | 1.1% | +236,400 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 673,400 | $4,105 萬 | 1.1% | −141,700−17.4% | 減碼 | 歷史 |
| ATECAlphatec Holdings, Inc. | COM NEW | 2,621,000 | $4,015 萬 | 1.1% | +287,000+12.3% | 加碼 | 歷史 |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 4,105,000 | $3,982 萬 | 1.1% | +90,000+2.2% | 加碼 | – |
| CYTCyteir Therapeutics, Inc. | COM | 1,808,394 | $3,870 萬 | 1.0% | +1,808,394 | 新進 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 1,000,000 | $3,815 萬 | 1.0% | +1,000,000 | 新進 | 歷史 |
| CAHCardinal Health Inc | Stock | 654,200 | $3,735 萬 | 1.0% | −808,800−55.3% | 減碼 | 歷史 |
| KDMNKadmon Holdings, Inc. | COM | 9,294,600 | $3,597 萬 | 1.0% | −249,600−2.6% | 減碼 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 3,400,000 | $3,349 萬 | 0.9% | −100,000−2.9% | 減碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 195,000 | $3,306 萬 | 0.9% | −232,969−54.4% | 減碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 1,150,050 | $3,273 萬 | 0.9% | +1,150,050 | 新進 | 歷史 |
| SPNESeaSpine Holdings Corp | COM | 1,524,998 | $3,128 萬 | 0.8% | +1,524,998 | 新進 | 歷史 |
| LFSTLifeStance Health Group, Inc. | COM | 1,100,000 | $3,065 萬 | 0.8% | +1,100,000 | 新進 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 1,003,522 | $2,944 萬 | 0.8% | +1,003,522 | 新進 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 625,000 | $2,566 萬 | 0.7% | +625,000 | 新進 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 601,000 | $2,347 萬 | 0.6% | +51,000+9.3% | 加碼 | 歷史 |
| ACETAdicet Bio, Inc. | COM | 2,250,500 | $2,316 萬 | 0.6% | +20,500+0.9% | 加碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 940,000 | $2,293 萬 | 0.6% | +940,000 | 新進 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 735,500 | $2,260 萬 | 0.6% | +735,500 | 新進 | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 1,500,000 | $2,081 萬 | 0.6% | +92,000+6.5% | 加碼 | 歷史 |
| PATHUiPath, Inc. | Stock | 300,000 | $2,038 萬 | 0.6% | +300,000 | 新進 | 歷史 |
| GRTSGritstone bio, Inc. | COM | 2,122,064 | $1,937 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| SIBNSI-BONE, Inc. | COM | 575,000 | $1,810 萬 | 0.5% | −2,570−0.4% | 減碼 | 歷史 |
| ZLABZai Lab Ltd | ADR | 100,000 | $1,770 萬 | 0.5% | +100,000 | 新進 | 歷史 |
| ORTXOrchard Therapeutics plc | ADS | 3,781,798 | $1,660 萬 | 0.4% | −536,002−12.4% | 減碼 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 1,450,000 | $1,643 萬 | 0.4% | −1,102,000−43.2% | 減碼 | 歷史 |
| PHASPhaseBio Pharmaceuticals Inc | COM | 4,315,000 | $1,605 萬 | 0.4% | +30,000+0.7% | 加碼 | 歷史 |
| SYNHSyneos Health, Inc. | CL A | 175,000 | $1,566 萬 | 0.4% | +175,000 | 新進 | 歷史 |
| SANASana Biotechnology, Inc. | COM | 778,597 | $1,531 萬 | 0.4% | +46,276+6.3% | 加碼 | 歷史 |
| SCYXScynexis Inc | COM NEW | 2,060,000 | $1,516 萬 | 0.4% | +796,231+63.0% | 加碼 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,495,000 | $1,346 萬 | 0.4% | −16,000−1.1% | 減碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 4,250,000 | $1,322 萬 | 0.4% | −2,547,400−37.5% | 減碼 | – |
| ACIUAC Immune SA | SHS | 1,584,000 | $1,256 萬 | 0.3% | +1,584,000 | 新進 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 560,000 | $1,217 萬 | 0.3% | +560,000 | 新進 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 1,125,000 | $1,136 萬 | 0.3% | +1,125,000 | 新進 | 歷史 |
| HOWLWerewolf Therapeutics, Inc. | COM | 650,265 | $1,134 萬 | 0.3% | +650,265 | 新進 | 歷史 |
| ZETAZeta Global Holdings Corp. | CL A | 1,300,000 | $1,092 萬 | 0.3% | +1,300,000 | 新進 | 歷史 |
| CMAXCareMax, Inc. | COM CL A | 817,402 | $1,054 萬 | 0.3% | +817,402 | 新進 | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 182,000 | $935.7 萬 | 0.3% | +182,000 | 新進 | 歷史 |
| CRDFCardiff Oncology, Inc. | COM | 1,395,000 | $927.7 萬 | 0.3% | −1,052,700−43.0% | 減碼 | 歷史 |
| MNDYmonday.com Ltd. | SHS | 40,000 | $894.4 萬 | 0.2% | +40,000 | 新進 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 1,400,010 | $883.4 萬 | 0.2% | +1,400,010 | 新進 | 歷史 |
| DOCSDoximity, Inc. | CL A | 150,000 | $873.0 萬 | 0.2% | +150,000 | 新進 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 104,000 | $861.3 萬 | 0.2% | +104,000 | 新進 | 歷史 |
| SSentinelOne, Inc. | CL A | 200,000 | $850.0 萬 | 0.2% | +200,000 | 新進 | 歷史 |
| ESPREsperion Therapeutics, Inc. | COM | 400,000 | $846.0 萬 | 0.2% | +400,000 | 新進 | 歷史 |
| ONCSOncosec Medical Inc | COM | 2,800,000 | $786.8 萬 | 0.2% | −670,000−19.3% | 減碼 | 歷史 |
| TILInstil Bio, Inc. | COM | 400,000 | $772.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 162,000 | $765.9 萬 | 0.2% | +162,000 | 新進 | 歷史 |
| PHVSPharvaris N.V. | COM | 400,000 | $745.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CM Life Sciences Inc18978W109 | COM CL A | 525,000 | $735.5 萬 | 0.2% | −25,000−4.5% | 減碼 | – |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 300,000 | $681.0 萬 | 0.2% | +300,000 | 新進 | 歷史 |
| DNLIDenali Therapeutics Inc. | COM | 86,100 | $675.4 萬 | 0.2% | +86,100 | 新進 | 歷史 |
| ATAIAtai Beckley N.V. | SHS | 350,987 | $649.3 萬 | 0.2% | +350,987 | 新進 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 436,363 | $641.0 萬 | 0.2% | +436,363 | 新進 | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 500,000 | $536.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $526.5 萬 | 0.1% | 00.0% | 不變 | – |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 520,000 | $501.8 萬 | 0.1% | +520,000 | 新進 | – |
| FIGSFIGS, Inc. | CL A | 100,000 | $501.0 萬 | 0.1% | +100,000 | 新進 | 歷史 |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $500.8 萬 | 0.1% | +500,000 | 新進 | – |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 500,000 | $497.0 萬 | 0.1% | +500,000 | 新進 | – |
| HYPRHyperfine, Inc. | CL A SHS | 500,000 | $492.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CELCCelcuity Inc. | COM | 200,000 | $480.0 萬 | 0.1% | +200,000 | 新進 | 歷史 |
| CFLTConfluent, Inc. | CLASS A COM | 100,000 | $475.0 萬 | 0.1% | +100,000 | 新進 | 歷史 |
| CM Life Sciences II Inc125842203 | UNIT 02/25/2028 | 330,000 | $443.9 萬 | 0.1% | −6,700−2.0% | 減碼 | – |
| Walkme LtdM97628107 | ORD SHS | 150,000 | $438.9 萬 | 0.1% | +150,000 | 新進 | – |
| MLTXMoonLake Immunotherapeutics | COM CL A | 400,000 | $414.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $408.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 400,000 | $400.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
2021 年第 1 季之後清倉（35 檔）
2021 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 1 季股數 | 2021 年第 1 季市值 | 2021 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| AZNAstraZeneca PLC | SPONSORED ADR | 3,650,500 | $1.82 億 | 5.1% | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 139,400 | $1.03 億 | 2.9% | 歷史 |
| BHCBausch Health Companies Inc. | Stock | 1,891,300 | $6,003 萬 | 1.7% | 歷史 |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 326,000 | $5,219 萬 | 1.5% | 歷史 |
| ChemoCentryx, Inc.16383L106 | COM | 940,800 | $4,821 萬 | 1.3% | – |
| ABMDAbiomed Inc | COM | 132,500 | $4,223 萬 | 1.2% | 歷史 |
| INOInovio Pharmaceuticals, Inc. | COM NEW | 4,004,391 | $3,716 萬 | 1.0% | 歷史 |
| CICigna Group | Stock | 135,000 | $3,264 萬 | 0.9% | 歷史 |
| LONALeonaBio, Inc. | COM | 1,677,845 | $3,087 萬 | 0.9% | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 707,359 | $2,948 萬 | 0.8% | 歷史 |
| ORGOOrganogenesis Holdings Inc. | COM | 1,463,403 | $2,666 萬 | 0.7% | 歷史 |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 1,330,700 | $2,463 萬 | 0.7% | 歷史 |
| CRISCuris Inc | COM NEW | 2,053,789 | $2,325 萬 | 0.6% | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,784,000 | $2,317 萬 | 0.6% | 歷史 |
| IGMSIGM Biosciences, Inc. | COM | 293,000 | $2,247 萬 | 0.6% | 歷史 |
| BOLTBolt Biotherapeutics, Inc. | COM | 654,294 | $2,153 萬 | 0.6% | 歷史 |
| CMRXChimerix Inc | COM | 2,230,000 | $2,150 萬 | 0.6% | 歷史 |
| BVSBioventus Inc. | COM CL A | 1,254,333 | $1,917 萬 | 0.5% | 歷史 |
| SGTXSigilon Therapeutics, Inc. | COM | 850,968 | $1,902 萬 | 0.5% | 歷史 |
| COLLCollegium Pharmaceutical, Inc | COM | 740,000 | $1,754 萬 | 0.5% | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 1,907,081 | $1,137 萬 | 0.3% | 歷史 |
| ADMSAdamas Pharmaceuticals Inc | COM | 2,200,200 | $1,056 萬 | 0.3% | 歷史 |
| Affimed N VN01045108 | COM | 1,296,000 | $1,025 萬 | 0.3% | – |
| MRUSMerus N.V. | COM | 487,000 | $1,017 萬 | 0.3% | 歷史 |
| IMTXImmatics N.V. | SHS | 884,600 | $991.6 萬 | 0.3% | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 400,000 | $880.0 萬 | 0.2% | 歷史 |
| EVLOEvelo Biosciences, Inc. | COM | 800,000 | $856.0 萬 | 0.2% | 歷史 |
| Vesper Healthcare Acqstn Cor92538T203 | UNIT 99/99/9999 | 600,000 | $693.0 萬 | 0.2% | – |
| Arya Sciences Acquisition CoG3166W106 | COM CL A | 500,000 | $689.0 萬 | 0.2% | – |
| ARGXArgenx SE | SPONSORED ADR | 20,000 | $550.8 萬 | 0.2% | 歷史 |
| Medicus Sciences AcquisitionG5960S116 | UNIT 99/99/9999 | 520,000 | $512.2 萬 | 0.1% | – |
| COGTCogent Biosciences, Inc. | COM | 417,710 | $366.7 萬 | 0.1% | 歷史 |
| EYPTEyePoint, Inc. | COM NEW | 232,504 | $236.2 萬 | 0.1% | 歷史 |
| ANNXAnnexon, Inc. | COM | 70,000 | $194.9 萬 | 0.1% | 歷史 |
| AMWLAmerican Well Corp | CL A | 70,250 | $122.0 萬 | <0.1% | 歷史 |